Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Published

Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.

ColonFlag is a solution that identifies patients who may experience gastrointestinal microbleeding caused by polyps or cancer. A positive result is an indication for colonoscopy.

ColonFlag helps make diagnostic decisions thanks to applying advanced AI algorithms to data from frequently performed laboratory tests. The programme analyses data such as the results of a CBC test and other data contained in electronic medical records.

- Dr Piotr Soszyński, Director of Medical Systems at Medicover Polska

This makes it possible for the tool to identify people who are in a high risk group and require further testing.

Colon cancer is the second most common cancer in women in Poland and the third among males. It is the fourth most common cause of death due to cancer. In Poland, the average survival rate after five years is slightly below 50%. If colorectal cancer is diagnosed at an early stage, the rate may even exceed 90%. Early detection has enormous importance for the successful treatment of colorectal cancer. ColonFlag can help us better identify patients in the high risk group. Thanks to this, referrals for colonoscopy may result in a better chance of detecting the disease and significantly improve the outcome of treatment.

- Dr Bożena Walewska-Zielecka, Medical Director at Medicover Polska

The success of the project may mean that Medicover Polska will begin using the ColonFlag tool in routine diagnostic procedures.

We are pleased to be working with Medicover on their first use of machine-learning algorithms to streamline the processes of diagnostic decision making. This is the first step towards integrating technology that will have a far-reaching impact on the work of doctors and medical service providers. It will give them tools to provide individualised care for patients in the high risk group. - Ori Geva, CEO of Medial EarlySign.
The pilot programme using the innovative method is being implemented at Medicover Centres in Warsaw and in the south of Poland. The single analysis is performed in Medicover patients between the ages of 50 and 75 who have had a complete blood count test performed for any reasons and agreed to participate in the project. Medial EarlySign is currently conducting clinical trials in more than 20 million patients in 14 institutions around the world.

Copy as a Plain Text

Share

Related Stories
Healthy baby - the challenge of modern times

ago

In 2016, over 382,000 births were recorded in Poland [1]. Research shows that two thirds of parents feed their children the wrong diet and expand their children’s diet too quickly [2]. The knowledge on how to take proper care of infants is still insufficient, which increases the risk of disease in later years. That is why regular medical check-ups for a newborn baby are so important to ensure that his health and development are constantly assessed. Constant paediatric care also enables parents to deepen their knowledge about the best ways to take care of their child's health.
Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board

ago

In June of this year, Dr Bożena Walewska-Zielecka was appointed to the Management Board of Medicover Sp. z o.o. and took over the post of Medical Director at Medicover. In her new role she will be responsible for medical quality, occupational medicine, prevention standards and the quality and risk management system, among others.
Nearly one in four Poles have thyroid dysfunction

ago

On one hand, weakness, excessive sleepiness, prone to freezing, weight gain and apathy. On the other, insomnia, feeling hot, weight loss, nervousness and irritability. All these symptoms can point to the dysfunction of the same gland - the thyroid. Experts estimate that more than 300 million people worldwide suffer from thyroid problems, but as many as half of them are not aware of the illness.
Medicover launches Health Innovators. Takes another step towards innovation.

ago

Medicover has launched a unit dedicated to healthcare innovation and collaboration with startups – Health Innovators by Medicover. It is a team whose mission is to implement innovative medical projects. As part of the project the company wants to build a community of innovators - made up of startups, patients and employees - and thus speed up the implementation of new solutions.

Healthy baby - the challenge of modern times

In 2016, over 382,000 births were recorded in Poland [1]. Research shows that two thirds of parents feed their children the wrong diet and expand their children’s diet too quickly [2]. The knowledge on how to take proper care of infants is still insufficient, which increases the risk of disease in later years. That is why regular medical check-ups for a newborn baby are so important to ensure that his health and development are constantly assessed. Constant paediatric care also enables parents to deepen their knowledge about the best ways to take care of their child's health.